Overview
Anne Beaven is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Beaven has been practicing medicine for over 24 years and is rated as an Experienced provider by MediFind in the treatment of Metastatic Brain Tumor. Her top areas of expertise are Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Aspiration, and Bone Marrow Transplant.
Her clinical research consists of co-authoring 61 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Metastatic Brain Tumor.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
101 Manning Dr, Chapel Hill, NC 27514
Additional Areas of Focus
Dr. Beaven has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
11 Clinical Trials
Duke Cancer Center
My clinical practice if focused on the care of patients with breast cancer, particularly those diagnosed at a younger age and those with recurrence in the central nervous system. I am committed to the care of patients with breast cancer brain metastases, and I am honored to serve as the Medical Director of the Brain and Spine Metastases Program in the Duke Cancer Center. In this role, our multidisciplinary team provides well-coordinated care for patients with breast cancer and other solid tumor types that have metastasized to the central nervous system. In addition, I enjoy helping young women diagnosed with breast cancer navigate their treatment decisions to ensure both excellent medical care and attention to individual challenges, such as future fertility, sequelae of treatment on longer-term health, and impact on current and future relationships. When not working, I enjoy running, reading, and traveling with my family. Dr. Anders is rated as an Elite provider by MediFind in the treatment of Metastatic Brain Tumor. Her top areas of expertise are Breast Cancer, Brain Tumor, Triple-Negative Breast Cancer, and HER-2 Positive Breast Cancer.
Duke Cancer Center
I am an academic adult and pediatric neuro-oncologist who helps lead The Preston Robert Tisch Brain Tumor Center at Duke. I am the author of more than 500 peer-reviewed articles, reviews, and book chapters, and I have presented extensively at both international and national meetings. I am a committed educator who is a member of the executive and super-executive committees of the Duke University School of Medicine, which are responsible for the recruitment, screening and selection of medical students. I have reviewed grants for the National Institutes of Health for over 15 years, in a spectrum of different study sections. I am the senior editor of CNS Oncology and a reviewer for over 25 academic journals. I serve on the advisory board of a number of organizations, including Voices Against Brain Cancer, the Tug McGraw Foundation, Pinnacle Care, the Pediatric Brain Tumor Foundation, the National Children’s Cancer Society, and the American Brain Tumor Association. Dr. Friedman is rated as an Elite provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Glioma, Astrocytoma, Glioblastoma, and Brain Tumor.
Duke Cancer Center
As a cancer doctor, I strive to provide the kind of care that I would want for my own family. My aim is to use my expertise, knowledge, and understanding of the human condition to empower patients. While scientific knowledge and approaches are at the core of what I do, I find it important to aim to integrate the human context into what my team and I offer patients and their families. Having lived, trained, and worked in different countries, including Australia, the United Kingdom, the Netherlands, and the United States, I have developed unique insights into the practice of medicine and cancer care around the world. These experiences have given me a broader perspective and helped inform my approach to individualized patient care. I see my ability to help patients as a privilege, and I do get enormous pleasure from being able to help. When not working, I am an avid reader and enjoy running, cycling, and spending time with my family. Dr. Khasraw is rated as an Elite provider by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Hip Replacement.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Non-Hodgkin LymphomaDr. Beaven isElite. Learn about Non-Hodgkin Lymphoma.
- Distinguished
- B-Cell LymphomaDr. Beaven isDistinguished. Learn about B-Cell Lymphoma.
- Classical Hodgkin LymphomaDr. Beaven isDistinguished. Learn about Classical Hodgkin Lymphoma.
- Cutaneous T-Cell Lymphoma (CTCL)Dr. Beaven isDistinguished. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Beaven isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Follicular LymphomaDr. Beaven isDistinguished. Learn about Follicular Lymphoma.
- Hodgkin LymphomaDr. Beaven isDistinguished. Learn about Hodgkin Lymphoma.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Beaven isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Anaplastic Large Cell LymphomaDr. Beaven isAdvanced. Learn about Anaplastic Large Cell Lymphoma.
- Angioimmunoblastic T-cell Lymphoma
- Bone Marrow AspirationDr. Beaven isAdvanced. Learn about Bone Marrow Aspiration.
- Febrile NeutropeniaDr. Beaven isAdvanced. Learn about Febrile Neutropenia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Beaven isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Adult T-Cell LeukemiaDr. Beaven isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Beaven isExperienced. Learn about Agranulocytosis.
- Aplastic AnemiaDr. Beaven isExperienced. Learn about Aplastic Anemia.
- Bone Marrow TransplantDr. Beaven isExperienced. Learn about Bone Marrow Transplant.


